Feasibility and efficacy of helical tomotherapy in cirrhotic patients with unresectable hepatocellular carcinoma

por Huang, Chun-Ming, Huang, Ming-Yii, Tang, Jen-Yang, Chen, Shinn-Cherng, Wang, Liang-Yen, Lin, Zu-Yau, Huang, Chih-Jen
Publicado 2015

High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study

por Yu, Ming-Lung, Dai, Chia-Yen, Chen, Shinn-Cherng, Lee, Li-Po, Hsieh, Ming-Yen, Lin, Zu-Yau, Hsieh, Ming-Yuh, Wang, Liang-Yen, Tsai, Jung-Fa, Chang, Wen-Yu, Chuang, Wan-Long
Publicado 2005

Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin

por Yu, Ming-Lung, Liu, Chen-Hua, Huang, Chung-Feng, Tseng, Tai-Chung, Huang, Jee-Fu, Dai, Chia-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Wang, Liang-Yen, Juo, Suh-Hang Hank, Chuang, Wan-Long, Kao, Jia-Horng
Publicado 2012

Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients

por Huang, Chung-Feng, Dai, Chia-Yen, Yeh, Ming-Lun, Huang, Jee-Fu, Huang, Ching-I, Hsieh, Ming-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Wang, Liang-Yen, Juo, Suh-Hang Hank, Chuang, Wan-Long, Lin, Yi-Ching, Yu, Ming-Lung
Publicado 2013